# Low-dose Y90 Treatment Planning for HCC

> **NCT04172714** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 30 (actual)

## Conditions studied

- HCC
- Cancer of Liver
- Cancer

## Interventions

- **DEVICE:** SIR-Spheres microspheres

## Key facts

- **NCT ID:** NCT04172714
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-16
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04172714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04172714, "Low-dose Y90 Treatment Planning for HCC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04172714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*